Views & Analysis | Perspectives on pharma industry issues

Oncology

On GDF-15 neutralisation and cachexia, with CatalYm

As ESMO 2026 continues to get underway, pharmaphorum web editor Nicole Raleigh spoke with Scott Clarke, CEO of CatalYm.

Oncology

pharmaphorum podcast Episode 282 at ESMO26: Dr Chuck Link, Syncromune

ESMO26: Lowering toxicity, extending lives, with Syncromune

As the ESMO26 Congress commences in Madrid, pharmaphorum invited Syncromune Executive Chairman Dr Chuck Link onto the podcast.

Oncology

Why precision biomarkers will change the future of breast ca...

Blood-based biomarkers can provide an earlier, dynamic view of what is happening inside a patient, creating an opportunity to detect changes sooner.

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Articles

CME in Europe: a fragmented environment

In this interview with Eva Thalmann of Janssen we discuss the current CME environment in Europe. The CME environment in Europe is evolving. There is a rise in the expectation of the pharmaceutical industry to support CME...

Articles

Connectivity: key to igniting marketing excellence

Samantha Clarke of UCB Pharma discusses UCB’s approach to marketing excellence and highlights why looking to brands outside of the pharma industry can be beneficial. When insurance giants CGU and Norwich Union merged in May 2000, over 40 different company trading names came together under...

Articles

Medic involvement in pharma marketing

Howard Goodall is senior advisor for oncology at Astellas. Here he addresses the merits of medic involvement in pharma marketing. Howard Goodall believes that, as a medic, his knowledge of and experience offer him a unique viewpoint from which to identify...

Sales & Marketing

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital